INFevo (无界进化)

INFevo (Beijing Infinite Evolution Technology Co., Ltd.) is an AI-native biotechnology startup incubated by XtalPi (2228.HK) in Beijing that builds AI virtual cell foundation models and automated wet-lab loops to predict cellular responses to genetic, chemical and environmental perturbations. Its OCOO model series, The Popper Project hypothesis engine and the Karl Workbench research workbench support target discovery, virtual drug screening and clinical protocol optimization, and in an October 2026 retest Karl Workbench ranked first in both the single-cell and spatial omics tracks of the SciAgentArena benchmark. The company also participates in the Beijing key laboratory for hepatobiliary-pancreatic tumor organoids and intelligent diagnosis led by Peking University First Hospital.

  • Seed
  • AI/ML
  • Biotechnology
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 16, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 16, 2026

    CNY 100M

    Seed

    • Huagai Capital
    • HSG (HongShan Capital/Sequoia China)
    • Shunwei Capital (顺为资本)
    • Prosperity7 Ventures
    • Huakong Fund (华控基金)
    • Songhe Capital (松禾创投)
    • LinkX Capital (星连资本)
    • DT Capital Partners (德同资本)

    Article coming soon.

Pricing

Research INFevo (无界进化) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if INFevo (无界进化) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational